Effects of Combined Thoracic and Diaphragmatic Breathing on Cognitive and Psycho-Physiological Fu… (NCT07620249) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effects of Combined Thoracic and Diaphragmatic Breathing on Cognitive and Psycho-Physiological Functions
60 participantsStarted 2026-05-25
Plain-language summary
This study aims to investigate the effects of a combined thoracic expansion exercise (TEE) and slow diaphragmatic breathing (SDB) program on cognitive function, brain activation, psychological status, and head-shoulder posture in healthy young adults.
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. age between 18 to 30 years with at least a high school education to ensure baseline cognitive task comprehension
. the ability to adhere to verbal instructions
. no regular participation in formal breathing exercise or mindfulness training within the past six months.
Exclusion criteria
. a history of musculoskeletal, cardiovascular, or cerebrovascular diseases which may interfere this study
. history of respiratory disease or recent respiratory infection
. diabetes mellitus with neuropathy, peripheral neuropathy, or other neurological disorders
. major surgery within the past six months
. Current or past major psychiatric disorders or cognitive impairment
. use of medications significantly affecting cerebral hemodynamics or autonomic function (e.g., beta-blockers, vasodilators) within the past 2 weeks
. use of psychotropic medications or substances known to alter cerebral blood flow, neural activation, or autonomic regulation (e.g., antidepressants, antipsychotics, anxiolytics, stimulants, or sedative-hypnotics).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from baseline in Working Memory
Timeframe: Baseline, Week 5 (post-intervention)
2
Change from baseline in Inhibitory Control
Timeframe: Baseline, Week 5 (post-intervention)
3
Change from baseline in Mental Set Shifting
Timeframe: Baseline, Week 5 (post-intervention)
4
Change from baseline in Short-Term Memory
Timeframe: Baseline, Week 5 (post-intervention)
Trial details
NCT IDNCT07620249
SponsorNational Taiwan University Clinical Trial Center